Study on tuberculosis outside the lungs
Part of Infections clinical trials.
This study tracks people with tuberculosis that is mainly outside the lungs (extrapulmonary TB). It collects medical information and samples to better understand the disease and improve care. If you have this type of TB, joining could help advance knowledge and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with tuberculosis (TB) outside the lungs (for example, in the lymph nodes, bones, abdomen, or other organs). The TB can also be in the lungs, but the main problem must be outside the lungs.
- The diagnosis must be confirmed by a lab test (like PCR or culture) or strongly suspected based on your symptoms, imaging, or exposure to someone with TB.
- You are able to give your written consent to participate.
- You are not pregnant.
- You are not in a situation that would make it hard to follow the study (like a language barrier you can't overcome, or being too weak to complete the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
This study is collecting information from people who are starting TB treatment to learn more about how well the treatment works. The goal is to better understand factors that influence TB treatment success.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study follows people who are newly treated for tuberculosis, including lung and non-lung (extra-lung) cases. It may help doctors better understand tuberculosis and how patients respond after treatment starts.
This trial looks at patterns of gene activity (from blood/tissue samples) in adults with spinal tuberculosis. The goal is to better understand the disease and how to tell different conditions apart, which may help future care.
Hear when a new Extrapulmonary Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.